Falsification of at-home isotretinoin pregnancy testing during the COVID-19 pandemic: A case series and proposal of mitigation strategies-Reference-Cited by-同舟云学术

Falsification of at-home isotretinoin pregnancy testing during the COVID-19 pandemic: A case series and proposal of mitigation strategies

Published:2022-10 Issue: Volume:28 Page:49-53
ISSN:2352-5126
Container-title:JAAD Case Reports
language:en
Short-container-title:JAAD Case Reports

Author:

Johnson Hadley,Ranum Alison,Mansh Matthew,Farah Ronda S.,Pearson David R.

Publisher

Elsevier BV

Subject

Dermatology

Reference4 articles.

1. Coronavirus (COVID-19) update: FDA provides update on patient access to certain REMS drugs during COVID-19 public health emergency. US Food and Drug Administration. Accessed May 6, 2022. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-provides-update-patient-access-certain-rems-drugs-during-covid-19

2. COVID-19 pandemic leading to the accelerated development of a virtual health model for isotretinoin;Kane;J Dermatol Nurses Assoc,2021

3. An opportunity for improvement: iPLEDGE policy changes during the coronavirus pandemic;Pathoulas;Dermatol Ther,2020

4. Measuring the rate of patients’ deliberate circumvention of iPledge pregnancy testing;Smith;J Am Acad Dermatol,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Teledermatology: Lessons Learned from the COVID-19 Pandemic;American Journal of Clinical Dermatology;2023-12-07

2. Home pregnancy tests for iPLEDGE: ethically dealing with potential falsifications;International Journal of Women’s Dermatology;2023-07-11

3. Commentary on intentional falsification of at-home pregnancy tests;JAAD Case Reports;2022-11